SCHEMBL1806987

SCHEMBL1806987

CCOC(=O)c1c(C)n[nH]c1-c1c(F)cccc1C1=NC(C)CN1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4D Q08499 1/20 0.39
ALOX5 P09917 2/20 0.36
NPC1 O15118 4/20 0.34
RAB9A P51151 3/20 0.34
SMN1; SMN2 Q16637 3/20 0.34
LMNA P02545 2/20 0.34
MAPT P10636 2/20 0.34
HTT P42858 2/20 0.34
TDP2 O95551 1/20 0.34
NSD2 O96028 1/20 0.34
THRB P10828 1/20 0.34
XBP1 P17861 1/20 0.34
GALK1 P51570 1/20 0.34
BLM P54132 1/20 0.34
PAX8 Q06710 1/20 0.34
ATM Q13315 1/20 0.34
KMT2A Q03164 1/20 0.34
DGAT1 O75907 1/20 0.34
SOAT1 P35610 1/20 0.34
ALDH1A1 P00352 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1806508 0.76 PDE4D (0.49) PDE4DALOX5NPC1RAB9ASMN1; SMN2
SCHEMBL1806224 0.76 PDE4D (0.41) PDE4DALOX5NPC1RAB9ASMN1; SMN2
SCHEMBL1807102 0.74 PDE4D (0.47) PDE4DALOX5NPC1RAB9ASMN1; SMN2
SCHEMBL1805096 0.74 PDE4D (0.47) PDE4DALOX5NPC1RAB9ASMN1; SMN2
SCHEMBL1804789 0.74 PDE4D (0.46) PDE4DALOX5NPC1RAB9ASMN1; SMN2
SCHEMBL1809876 0.74 PDE4D (0.46) PDE4DNPC1RAB9ASMN1; SMN2LMNA
SCHEMBL1806318 0.73 PDE4D (0.50) PDE4DALOX5NPC1RAB9ASMN1; SMN2
SCHEMBL1805132 0.71 NPC1 (0.43) PDE4DALOX5NPC1RAB9ASMN1; SMN2
SCHEMBL1803878 0.69 SLC6A2 (0.40) PDE4DNPC1RAB9ALMNATHRB
SCHEMBL19209480 0.66 PDE4D (0.59) PDE4DNPC1RAB9ASMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2501704-A1 SPIROPIPERIDINE COMPOUNDS AS ORL-1 RECEPTOR ANTAGONISTS Eli Lilly and Company (US) 2012-09-26 EP disclosed
WO-2011060217-A1 SPIROPIPERIDINE COMPOUNDS AS ORL-1 RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY (US) 2011-05-19 WO disclosed